LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has scheduled the release of its financial results for the fourth quarter and full year ended December 31, 2024, for Monday, March 24, 2025. … ...

LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ...

First Quarter 2025 Financial Results Conference Call Date: May 13, 2025 Time: 4:30 P.M. ET Live Call: 1-800-343-4849 (U.S. Toll Free) or 1-203-518-9848 (International) Webcast: Events and ...

Nexgel, which has 10 employees, recorded revenue of $1.55 million and a net loss of $4.3 million in 2021. Related Articles . Baudax completes $5M stock sale; Incyte licenses skin disease therapy ...

NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025 Provided by GlobeNewswire Mar 13, 2025, 1:00:00 PM ...

--NEXGEL, Inc., a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the ...